retatrutide dosing frequency clinical trials Reta trial data & — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 for metabolic health — targeting GLP-1, GIP retatrutide dosing frequency clinical trial

It mimics two hormones, GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)

Addressing Multiple Facets of Metabolic Health Obesity and metabolic syndrome are complex conditions involving multiple dysfunctions, from hormonal imbalances to cellular energy deficits

At Pure Medical Spa, our expert medical team evaluates your individual health profile to recommend the most effective and sustainable treatment planoften combining GLP-1 therapy with nutritional guidance, lifestyle support, and accountability check-ins

No, the abdomen and thigh provide equivalent absorption and effectiveness when tirzepatide is properly injected

Side effects may be more noticeable during escalation, although the pattern can differ by person